Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Operating expenses
Research and development	$ 2,206,158	$ 1,659,075	$ 7,383,281	$ 4,250,934
General and administrative	2,952,436	1,849,741	8,309,807	6,130,698
Total operating expenses	5,158,594	3,508,816	15,693,088	10,381,632
Operating loss	(5,158,594)	(3,508,816)	(15,693,088)	(10,381,632)
Other income (expense), net	(38,551)	17,745	(81,374)	36,999
Loss before income taxes	(5,197,145)	(3,491,071)	(15,774,462)	(10,344,633)
Income taxes	0	0	0	0
Net loss	$ (5,197,145)	$ (3,491,071)	$ (15,774,462)	$ (10,344,633)
Loss per common share - basic and diluted (in dollars per share)	$ (0.04)	$ (0.34)	$ (0.14)	$ (1.09)
Weighted average shares outstanding - basic and diluted (in shares)	126,537,544	10,162,770	113,689,961	9,496,222